The Sensational Dip in This Growth Stock Can Be an Excellent Opportunity

Insiders bought at higher prices! The +8% dip in Jamieson Wellness Inc. (TSX:JWEL) stock before earnings can be a great buying opportunity.

| More on:
Where to Invest?

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

This may be another chance to buy growth stock Jamieson Wellness (TSX:JWEL). The stock fell +8% on Thursday without the company releasing any news. Further investigation indicated that an analyst downgrade of the stock to a “hold” and a price target of $23 per share led to the selloff.

The latest stock purchases from multiple insiders occurred in 2018, ranging largely from $19-22 per share. The largest number of shares bought occurred in November. These were purchases of more than 15,600 shares and 10,000 shares, respectively, for $20 and $21.39 per share, by two insiders. So, the fact that the stock dropped below $19 may be a good price to buy some shares if you’re bullish on the stock for the long term.

How fast is Jamieson growing? Is it profitable?

From 2014-2017, Jamieson increased its revenue from $210 million to $300 million at a compound annual growth rate of 12.5%. In the period, it wasn’t profitable, but had improved with lower losses over time.

2018 was a profitable year for Jamieson. In the first nine months of the year, it generated revenue of more than $230 million, gross profit of more than $79 million, and net income of over $16.6 million, which implies a gross margin of 34.4% and net margin of 7.2%.

fruits, groceries

What Jamieson does

Jamieson manufactures, distributes, and markets branded natural healthcare products, including vitamins, minerals, and supplements (VMS). It has a number one position in Canada with a market share of 25% at food, drug, and mass stores, such as Superstore and London Drugs. For their convenience, consumers can also shop Jamieson’s products online at Amazon and Costco, among others.

Jamieson offers a diversified range of premium products across multiple distribution channels. This branded segment contributes to about 80% of revenue. It will continue to come out with innovative products to attract consumers.

Other than its branded segment, Jamieson also partners with manufacturers, blue-chip consumer health companies, and retailers around the world with the aim of leveraging infrastructure and reduce costs. This segment contributes to about 20% of revenue.

Investor takeaway

A more health-conscious crowd can be a growth driver for Jamieson. The VMS and sports nutrition are growing segments in the consumer health industry. In Canada, in terms of sales, Jamieson takes the first place in the overall consumer health brand and as a VMS brand. It also sells its products globally in 40 countries. Increasing its brand awareness can drive immense growth in countries where it’s less well known.

At $18.91 per share as of writing, Jamieson trades at an estimated 2018 P/E of just under 22. It’s growing at a double-digit rate, so the multiple is warranted.

That said, Jamieson will report its Q4 and full year 2018 results in about two weeks. Cautious investors may wish to wait for those results before considering a purchase. If you like the long-term prospects of Jamieson, consider picking up a small position here on the dip and decide on the next course of action after reviewing its Q4 and 2018 results.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Kay Ng owns shares of Amazon. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Dividend Stocks

money cash dividends
Dividend Stocks

TFSA Passive Income: 2 Top TSX Dividend Stocks to Buy on the Correction

These top dividend stocks look cheap to buy right now for a TFSA focused on passive income.

Read more »

Target. Stand out from the crowd
Dividend Stocks

2 Oversold TSX Stocks to Buy in July

Invests can now find good value right now in top TSX dividend stocks.

Read more »

You Should Know This
Dividend Stocks

OSFI: Mortgage Arrears Only 0.15% Despite Rate Hikes

The OSFI is happy with the low mortgage delinquency but remains worried over the impact of rising rates on Canadian…

Read more »

Female hand holding piggy bank. Save money and financial investment
Dividend Stocks

2 Great TSX Stocks to Start a TFSA Retirement Fund During a Market Correction

These top TSX dividend stocks look cheap right now to buy for a TFSA retirement portfolio focused on passive income…

Read more »

consider the options
Dividend Stocks

Recession Worries? Try Buying These 2 Stocks

Consider investing in these two safe dividend stocks if you are worried about your investment returns due to fears of…

Read more »

A close up image of Canadian $20 Dollar bills
Dividend Stocks

TFSA Investors: Should You Be Holding Cash Now?

Holding cash might not be the best option for TFSA investors in 2022, but using surplus cash to purchase dividend…

Read more »

stock market
Dividend Stocks

4 Dividend Stocks With Yields of at Least 5% in a Bearish Market

By investing in these stocks, investors can earn reliable dividend yield of 5% or more.

Read more »

Path to retirement
Dividend Stocks

Retirement Investors: 2 Top Defensive TSX Stocks to Own During a Recession

These top defensive TSX dividend stocks look good to buy for a retirement fund during an economic downturn.

Read more »